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Abstract:  The  synthesis  of  histamine  H2  receptors  peptides  was 
conducted  using  the  methodology  of  solid  phase  assisted  by  micro-
waves. Microwaves can reduce the reaction times during the coupling 
and  deprotection  steps  to  obtain  the  desired  peptide  sequence. The 
coupling reaction was carried out with a mixture of N,N′-diisopropyl-
carbodiimide  (DIC)  and N,N,N′,N′-tetramethyl-O-(1H-benzotriazol-
1-yl)uronium  hexafluorophosphate  (HBTU). The  purity  and  yield 
are improved in peptide synthesis assisted by microwaves. Coupling 
reactions  and  deprotection  on  Rink  resin  were  carried  out  in  5  min 
depending on amino acid and the length of the peptide chain.
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Resumen:  La  síntesis  de  péptidos  receptores  de  histamina  H2  fue 
realizada empleando la metodología de síntesis en fase sólida asistida 
por  microondas.  Las  microondas  permitieron  disminuir  los  tiempos 
de  reacción  durante  las  etapas  acoplamiento  y  desprotección  para 
obtener la secuencia deseada de péptido. La reacción de acoplamiento 
se  llevó  a  cabo  con  una  mezcla  de  N,N´-diisopripilcarbodimida  y 
N,N,N′,N′-tetrametil-O-(1H-benzotriazol-1-il)uronio  hexafluoro-







While  the  deoxyribonucleic  acid  (DNA)  is  the  vital  part  of 
living beings, so are the peptides and proteins which have the 
role  of  the  construction,  maintenance  and  support  of  them. 
Proteins  and  peptides  are  naturally  occurring  formed  from  a 
limited  number  of  natural  L-amino  acids,  however  the  diver-
sity of structures, properties and the abundance of the protein 
compounds ensure its presence in all biological species on the 
planet.  [1] Hence, proteins  are present  in nature  to play vital 
roles  in  the  functioning of  almost  all biological  systems,  act-
ing as an extracellular messenger in animals and plants, or as 
hormones,  neuromodulators  and  neurotransmitters,  also  have 
a major impact on vital functions such as metabolism, respira-
tion and reproduction.
Several  authors have devoted  their  research  to  the  study, 
synthesis  and  sequence  of  peptides. These  synthetic  peptides 
in their three-dimensional conformers can be used as drugs or 
serve  as  antigens  to  stimulate  the  formation  of  specific  anti-
bodies [2].
The solid phase synthesis (SPOS) has been widely used in 











of  the amino acid and  the activation of  this group  is  the  first 
step  [5-8]. When  the  acid  has  a  stereogenic  carbon  in  the α 
position with respect to the carbonyl, as in the α-amino acids, 
then there is a high probability this center can racemize. This 
process  is  a  side  reaction,  which  should  be  avoided  in  order 




The  extent  of  racemization  depends  on  the  activation 
method  employed  in  methods  that  use  bases  there  will  be 





N,N′-Diisopropylcarbodiimide (DIC), shown to be the best 







The  importance  of  histamine  in  regulation  of  gastric 
acid  secretion  was  well  established,  the  end-organ  receptor 
mediating  this  action  could  not  be  defined  until  Black  et al. 
[11] developed an antagonist for the H2 subtype of histamine 
receptor on the basis of simple analogy to p adrenergic recep-
tor  antagonists. The  newly  developed  H2  histamine  receptor 
antagonist has since become the cornerstone of peptidic ulcer 
therapy. Early pharmacological studies [12, 13] indicated that 
the  bioactive  form  of  histamine  was  a  mono-cation  and  that 
imidazole tautomerism was important in binding of histamine 
to  H2,  but  not  H1  histamine  receptors.  From  these  studies, 
Weinstein  et al.  [13] proposed  a  three-site  model  predicting 
the requirement for negatively charged amino acid residues on 
the H2 histamine  receptor  to  interact with  the charged amine 
and  N(3)H moieties  of  histamine  and  a  third  receptor  amino 
acid  residue which would serve as an H-bond donor  to  inter-




of  both  histamine  and  basic  antagonists  for  both  receptors. 




The  design  of  the  synthesize  peptides  sequences  was  made 






position  five will  be  aspartic  acid  and position nine  is  threo-




were  evaluated  by  molecular  fluorescence  spectroscopy  [15] 
when  they  was  immobilized  on  the  polymer  support  (resin) 
and subsequently cleavage for their characterization by HPLC-
ESI-MS. Cleavage  from  resin was making with a  solution of 
TFA/TRIS/H2O/dithiotreitol  at  room  temperature  stirring  for 
6 h; Then,  the mixture was filtered and washed with CH2Cl2, 
MeOH.  The  filtrate  was  concentrated  at  a  temperature  not 




tion  occurred  at  75  °C  at  50 Watts  and  deprotection  reaction 
occurred at 75 °C at 40 Watts. After complete reaction time the 
resins were assessed by the Kaiser test for the identification of 









The  peptide  Tyr-Ala-Gly-Ile-Asp was  characterized  by 
HPLC-ESI-MS  using  as  mobile  phase  a  mixture  of  acetoni-
trile/water  (20/80) with 0.1% formic acid, presenting a  reten-
tion time of 1.0 minute.
Scheme 2.  Synthesis  of  pseudo-peptides  in  solid  phase  assisted  by 
microwaves.
Scheme 3. General methodology of peptide synthesis  in solid phase 
coupling and desprotection reactions.
Alanine Ala A Leucine Leu L
Aspartic acid Asp D Phenylalanine Phe F
Cysteine Cys C Threonine Thr T





Sequence % yield % purity [M + H]+
1. YAGID 92 % 93 % 537
2. YAGFDAGFT 89 % 90 % 946
3. YLGADLGAT 90 % 90 % 880
4. YLLLDLLLT 82 % 80 % 1076
5. YFFFDFFFT 70 % 85 % 1280
6. YGGGDGGGT 55 % 60 % 739
7. YAAADAAAT 85 % 95 % 823
8. YCCCDCCCT 75 % 60 % 1016







The  peptide  Tyr-Ala-Gly-Phe-Asp-Ala-Gly-Phe-Thr 
which  remains  in  the  first  position  with  a  tyrosine  residue, 
position five with aspartic acid residue and position nine with 
threonine residues obtained this sequence by the methodology 
of  synthesis  assisted  by  microwave  was  analyzed  by  HPLC 
using as mobile phase a mixture of acetonitrile/water  (20/80) 
with  0.1%  formic  acid,  presenting  a  retention  time  of  4.5 
minutes. In the mass spectrum by electrospray ionization was 
determined peak [M + H] at 946.6 m/z with a 100% isotopic 
abundance  corresponding  to  the  expected  molecular  weight 
of  946  also  in  the  mass  spectrum  (Figure  2)  shows  the  peak 
[M  +  H]  +  1  to  947.6  m/z  with  an  isotopic  abundance  of 







time  of  2.65  minutes.  In  the  mass  spectrum  by  electrospray 
insertion  was  determined  peak  [M  +  H]  at  879.9  m/z  with 
a  100%  isotopic  abundance  corresponding  to  the  expected 
molecular weight of 879 also in the mass spectrum shows the 
peak  [M + H] + 1  to 880 m/z  and  [M + H] + 2  to 881 m/z. 
Peptide  Tyr-Leu-Leu-Leu-Asp-Leu-Leu-Leu-Thr shows  a 
retention time of 1.65 minutes with a yield of 80% for peptide 
Tyr-Phe-Phe-Phe-Asp-Phe-Phe-Phe-Thr the  retention  time 
is 2.746 minutes with a yield of 70% and purity of 85%. The 
sequence with high percent of residue of glycine Tyr-Gly-Gly-




result  shows  that  purity  was  better  in  microwave  conditions 
than RT. The  low yield  and purity of  the peptide obtained  at 











General. All  reagents  were  purchased  in  the  higher  qual-
ity  available  and  were  used  without  further  purification. The 
solvents used  in column chromatography were obtained from 
commercial  suppliers  and  used  without  further  distillation. 
Infrared spectra (FTIR) were recorded on a Perkin Elmer FT-
IR  1600  spectrophotometer.  Liquid  chromatograms  (HPLC) 
were  obtained  on  an Agilent  1100  Series  LC  with  a  reverse 
Table 3. Signals presents  in  the mass  spectrum of peptide Tyr-Ala-
Gly-Ile-Asp.
Signal m/z Intensity % Relative isotopic 
abundance
[M+H] 537.6 183994 100
[M+H]+1 538.4 47096 25.5
[M+H]+2 539.4 11451 6.2
Table 4. Signals presents  in  the mass  spectrum of peptide Tyr-Ala-
Gly-Phe-Asp-Ala-Gly-Phe-Thr.
Signal m/z Intensity % Relative isotopic 
abundance
[M+H] 946.6 1610231 100
[M+H]+1 947.6 881925 55.3
[M+H]+2 948.6 287796 17.8














532 534 536 538 540 542 m/z














940 942 944 946 948 950 952 954 956 m/z
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phase ZORBAX sβ-C18 column (5 mm, 3 × 150 mm) and 





Activation of Rink resin. To  a  mixture  of  Rink-Fmoc  resin 
(1 g, 1.4 mmoles) in NMP (10 mL), was added 20 mL a solu-
tion  of  piperidine/Dicholomethane  (20%)  and  stirred  for  24 
h at RT. The resin was filtered and washed (3 × 10mL) with 
DMF,  MeOH  and  CH2Cl2 and  dried  for  2  h  under  reduced 
pressure. The  resin was  characterized by FT-IR  (KBr):  3380, 
3059,  2853,  1676,  1591,  1498,  1452,  1379,  1205,  1028,  751 
cm-1 and  the Kaiser’s  test  procedure was  carried out by dual 
protocol.
Incorporation of the first amino acid. To a mixture of Rink-
NH2  resin  (1.0 g, 1.4 mmoles)  in NMP (10 mL), was added; 
tyrosine (1.608 g, 7 mmol), HBTU (1.327 g, 7 mmoles), DIC 
(0.883  g,  7  mmol)  and  a  solution  of  DIPEA  (0.271  g,  4.2 
mmol)  in  NMP  (2  mL),  the  mixture  was  stirred  for  24  h  at 
RT. The resin was filtered and washed (3 × 10mL) with DMF, 
MeOH and CH2Cl2, and dried for 2 h under reduced pressure. 
The  resin  was  characterized  by  FT-IR  (3022,  2924,  1666, 
1496,  1382,  1250,  1034,  763)  cm-1.  Kaiser’s  test  procedure 
was carried out by dual protocol.
Synthesis of peptide histamine H2 receptors on Rink-
Tyrosine resins assisted by microwave. To  a  mixture  of 
Rink-Tyrosine-Fmoc  resin  (0.2  g,  0.28  mmol)  was  removed 
the Fmoc group to be the amine free, with a solution of piperi-
dine/Dicholomethane  (20%).  The  mixture  was  assisted  by 
microwave  (75°C,  50 W,  5  minutes)  with  dual  protocol,  the 






(1  mL). The  mixture  was  assisted  by  microwave  (75  °C,  40 
W, 5 min) with two protocols. The resin was washed (3 × 10 




the  crude  and  the  purification  was  carried  out  in  cold  ethyl 
ether (5 × 10 mL).
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